Fusion Pharmaceuticals Inc.
ON - Hamilton
Pharmaceutical5 H-1B visas (FY2023)Focus: Targeted Alpha Therapeutics for chemo-resistant Cancers
Fusion Pharmaceuticals Inc. is a life sciences company focused on Targeted Alpha Therapeutics for chemo-resistant Cancers.
OncologyNeurology
Funding Stage
PUBLIC
Open Jobs
0
Products & Portfolio (1)
Pipeline & Clinical Trials
Utilization of Serenita for Relaxation
Erectile DysfunctionClinical Trials (1)
NCT02757807Stress Management Using an App to Improve Response With PDE5 Inhibitors in Men With Erectile Dysfunction.
N/ALifestyle Intervention
Sleep DisorderClinical Trials (1)
NCT03984058Recruitment Strategies Comparing Different Strategies in Sleep Apnea and Prediabetes
N/Asuspected of COVID-19 infection
Covid19Clinical Trials (1)
NCT04615208Screening for COVID-19
N/AStress Reduction& Healthy living
DiabetesClinical Trials (1)
NCT02621008Mobile Phone-based Intervention for Promoting Healthy Habits and Weight Loss
N/ABMF-219
Non Small Cell Lung CancerClinical Trials (1)
NCT05631574Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer
Phase 1[111In]-FPI-1547 Injection
Advanced Solid TumoursClinical Trials (1)
NCT03746431A Phase 1 Study of [225Ac]-FPI-1434 Injection
Phase 1BMF-219
Acute Myeloid LeukemiaClinical Trials (1)
NCT05153330Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
Phase 1BMF-500
Acute Myeloid LeukemiaClinical Trials (1)
NCT05918692A Phase 1 Study of BMF-500 in Adults With Acute Leukemia
Phase 1BMF-650
ObesityClinical Trials (1)
NCT07223216Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants
Phase 1[211At]NaAt
DTC - Differentiated Thyroid CancerClinical Trials (1)
NCT07287748A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer
Phase 1Icovamenib
Healthy VolunteerClinical Trials (1)
NCT07254286Food Effect Study in Healthy Volunteers
Phase 1BMF-219
Type 2 Diabetes MellitusClinical Trials (1)
NCT05731544Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)
Phase 1/2[225Ac]-FPI-1966
Advanced Solid TumorClinical Trials (1)
NCT05363605A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours
Phase 1/2PF-114
Chronic Myeloid LeukemiaClinical Trials (1)
NCT02885766Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene
Phase 1/2Phase 2
Clinical Trials (1)
NCT06909825FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2Phase 2
Clinical Trials (1)
NCT05219500Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).
Phase 2Phase 2
Clinical Trials (1)
NCT06402331FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2BMF-219
Type 1 Diabetes MellitusClinical Trials (1)
NCT06152042Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 1 approved product, 18 clinical trials
H-1B (2023): 5 approvals
Portfolio Health
LOE Approaching1 (100%)
1 total products
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
5
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub